Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance

Lei Shi(Chinese PLA General Hospital), Fenghuang Zhan(Winthrop Rockefeller Foundation)
Oncotarget
May 15, 2010
Cited by 113


Related Papers